-- Daiichi Sankyo (TYO:4568) has rescheduled the announcement of its consolidated financial results for the fiscal year 2025 from April 27 to May 11, citing the need for additional time to finalize figures.
The delay is primarily due to a review of supply plans for its oncology portfolio, which requires further deliberation to reasonably estimate loss provisions related to contracts with manufacturers, according to a Tokyo bourse filing on Monday.
The company also moved the announcement of its 5-year Business Plan (FY2026-FY2030) from May 19 to align with the new results date on May 11.